PRF1 and type 2 diabetes mellitus: Following Mtb-antigen stimulation, patients with LTBI-T2DM showed lower frequencies of CD8+ Tc1, Tc2, and Tc17 cells, with elevated cytotoxic markers (perforin and granzymes) than those without T2DM and reversing upon ATB development (90).